← Open Payments lookup

ABISOYE OTUNUGA: Open Payments

NPI 1659098416 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$879 in 38 payments from 9 companies in 2025. Trend: 2023 $236 · 2024 $1,393 · 2025 $879

Food & beverage: $768Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.8$206
ABBVIE INC.5$168
Otsuka America Pharmaceutical, Inc.8$162
Neurocrine BioSciences, Inc.5$87
Janssen Pharmaceuticals, Inc2$76
Vanda Pharmaceuticals Inc.4$64
Supernus Pharmaceuticals, Inc.2$45
Lundbeck LLC2$40
E.R. Squibb & Sons, L.L.C.2$33

Products named: VRAYLAR, UZEDY, REXULTI, INGREZZA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, ABILIFY MAINTENA, HETLIOZ.

Industry payments across NJ — which companies pay providers there.